Introduction
Some patients ~'ith cancer also develop neurologie syndromes which cannot be explained by metabolic or nutritional disorders, the complications of cancer therapy or metastasis. Although such cases must have been seen b y physicians for a long time, their identification in the medical literature seems to date no farther back than 1938. Brain and Norris (1965) collected the syndromes in question and reviewed much of the literature available through 1964. Subsequent reports by other authors and additional experience, including interesting new observations, now permit a re-evaluation of these remote effects. A classification is presented in Table 1A .
First, it should be emphasized that the neurological remote effects can lead to disorder at any level of the nervous system I brain, spinal cord, nerves, muscles --singly or in combination, so that the clinical picture may be confusing. In some cases, a relatively pure neurologic syndrome results, which we shall assume in this review. We shall also assume exclusion of metabolic/nutritional disorders (Table 1 B) .
Encephalopathies
Multi~ocal Leukoeneephalopathy (PML) : This disorder is predominantly a disease of the cerebral hemispheres and usually presents with disorders of mentation, speech (aphasia) and consciousness which tend to develop rapidly. I n m a n y cases, the neoplastic process has been in F. H. Norris, Jr. : remission when the neurologic disorder appeared. The neuropathology is characterized by demyelination and microscopically by bizarre cell changes with inclusion bodies. This carcinomatous "degeneration" is closely linked to virus infection: the residual glial nuclei in the lesions contain virus-like particles (ZuRhein and Chou, 1968) which, when isolated and negatively stained, possess the structural characteristics of papova virus (Schwerdt el al., 1966) . This virus has now been transmitted to a human glial cell culture (Padgett et al., 1971) .
PML is presumably a viral encephalitis having atypical features because of the unusual pathogen in a patient with altered immunologic responses (Brain and Norris, 1965; Ellison, 1969) . A tenable argument can also be made, however, that the demyelination in a patient with depressed immunologic mechanisms leads to secondary infection by a passenger virus. According to this viewpoint, the virus might increase the original brain lesion but does not cause it. The transmission of encephalitogenic activity from the brains of PML patients to laboratory animals is needed before we can conclude that the papova virus causes the brain lesions. Another fascinating problem is the relationship of the virus to the lymphocytic neoplasm.
PML has been documented in a previously-healthy man in whom no neoplasm or other condition was found at the necropsy (Fermaglieh et al., 1970) . The patient's immunologic status in life was not investigated, however, and such a disorder could have been missed in the necropsy. An important point for the clinician is that the brain scan can be positive in PML (Mosher et al., 1971) .
Other EnceThalopathies: Cases of more or less diffuse eneephalitic disease of the cerebral gray matter, polioencephalitis (Table 1A) , have been described by Henson (1965) and Viek (1969) and colleagues. The former noted that 8 of 10 eases were associated with bronehogenie carcinoma. Predilection for the temporal lobes has been reported (Corsellis et al., 1968) . No specific evidence of virus has been found, in particular inclusion bodies have not been seen although herpes simplex is the agent most apt to produce temporal lobe encephalitis. Other cases of poliocncephalopathy are not accompanied by histologie evidence of infection: the neuropathology may reveal very focal degeneration of neurons. In a patient with bronehogenie carcinoma, dementia and fits, the necropsy revealed selective neuronal degeneration in certain thalamic nuclei (Daniels et al., 1969) ; inappropriate ADH secretion was probably caused by the neoplasm, no relevant brain lesion being found.
A subavute cerebellar syndrome with prominent ataxia, speech difficulty (dysarthria) and nystagmus tends to be associated with lung carcinoma in older men and with ovarian carcinoma in women; the main neuropathology is marked loss of Purkinje cells.
To this type of CNS involvement we now add the dramatic syndrome of opsoclonus, the first remote effect seen mainly in children. Opsoclonus was described many years ago but the first case associated with a neoplasm was reported in a 63-year-old man with lung carcinoma by Ross and Zeman (1967) . The jerky, conjugate but asymmetrical "dancing eye" movements in all directions were then noted in two infants with neuroblastoma by Solomon and Chutorian (1968) . Tumor resection led to neurologie improvement, as also occurred in cases cited by others Brissaud and Beauvais, 1969; Bray et al., 1969; Moe and Nellhaus, 1970; Martin and Griffith, 1971; Sandok and Kranz, 1971) . Dyken and Kolar (1968) found elevated levels of serum and CSF IgG in two cases of opsoclonus, one with neuroblastoma, and Moe and Nellhaus (1970) found such a globulin abnormality in one their cases. This finding might indicate an auto-immune process, and cortieosteroid treatment is beneficial. The release of an active substance from the tumor (in addition to catecholamines) during surgical manipulation is suggested by the reports of further neurologic deterioration in the immediate postoperative period (Solomon and Chutorian, 1968 ; Moe and Nellhaus, 1970) . Such an agent might be an antigen which ehcits an immune response modified by corticosteroid therapy. An important step in future cases is study of excised tumor tissue, particularly whether it can be used to produce experimental allergic encephalomyehtis (EAE). The pathology remains to be described in an infant with neuroblastoma. In adults, marked cerebellar pathology in the dentate nucleus has been found in two cases (Ross and Zeman, 1967; Ellenberger et al., 1968) .
Myelopathies
Spinal cord lesions have been prominent in many of the encephalopathies, particularly pohoencephahtis and adult eerebellar encephalopathy. A combination of ventral horn motor neuron degeneration and cortieospinal tract demyehnation occasionally produces an amyotrophic picture in cancer patients (Brain et al., 1969) . Such patients tend to be older with more slowly progressive disabihty than in classical amyotrophic lateral sclerosis. In a recent review of the neuropathology, prominent inflammation in some cases raised the question of atypical virus infection (Norris et al., 1969) ; electron microscopic study of one case revealed unusual nuclear particles (Norris et al., 1970) . Other instances of "pohomyelitis" in cancer patients have been reported (Walton et al., 1968; Adams et al., 1970) . Peters and Clatauoff (1968) studied a patient with macroglobulinemia and amyotrophy; the latter improved after chlorambucil therapy. The mechanism is not clear, since the serum globulin abnormality was not greatly altered by the therapy and the necropsy was incomplete. Heesen et al. (1971) also noted neurologic improvement in a case of radiculopathy during treatment of paraproteinemia. Shy and Silverstein (1965) emphasized the frequency of motor neuron findings in patients with neuromuscular remote effects of cancer. They felt, however, that the marked amyotrophic syndrome might be due to the coincidence of two common diseases. In their series of 186 patients with amyotrophie lateral sclerosis, 9 also had malignant disease. More is said below about this point.
Necrotic myelopathy is a very rare disorder in which rapidly-ascending paraplegia precipitates a terminal state (Mancall and Rosales, 1964) . Profound sensory loss and incontinence also distinguish it from the amyotrophy just described. The neuropathology is notable for extensive necrosis of the spinal cord. The nature of the association between necrotic myelopathy and carcinoma also remains uncertain because of the rarity of this myelopathy and other possibilities, such as abdominal venous compression by tumor, tumor-induced thrombophlebitis, and pre-existing vascular malformation with secondary spinal cord necrosis. Richter and Moore (1968) had two cases of necrotic myelopathy associated with lymphoma. In one, the neoplasm was in remission and no trace of it was found at the necropsy. The other patient had a large retroperitoneal tumor mass, but necrotic loci were also found in the brain. Both patients had normal blood vessels.
Neuropathies
The most common neurological remote effect is flaccid weakness, sensory loss and arreflexia commencing in the feet and hands, later ascending the legs and arms, due to peripheral sensorimotor neuro~tthy. This is the familiar polyneuropathy or "neuritis" and the differential diagnosis is lengthy, especially in debilitated patients. Croft et al. (1967) identified three types of neuropathy: A, with well established malignancy and mild or terminal neuropathy; B, with acute or subacute severe neuropathy, sometimes before discovery of the neoplasm; and C, with relapsing neuropathy. Lung carcinoma was present in 16 of 25 cases in the first two groups, but in only one of 8 cases of the remitting type. The common pathologic lesion was segmental demyelination of the peripheral nerves.
The propensity of bronehogenic oat-cell carcinoma to secrete bioactive substances raises the possibility that the tumor produces an agent which leads to the neural lesion. One patient with oat-cell carcinoma had confusional psychosis, peripheral neuropathy, hyperadrenalism and water retention. The necropsy revealed high ACTH-like activity in a metastasis and depletion of pituitary ACTH (Sethurajan et al., 1967) . Perhaps this neoplasm secreted another substance which led to the nerve damage.
In the very rare sensory neuro~tthy where the major neuropathology is inflammation of the dorsal root ganglia, serum antibodies against neurons have been detected, again in patients with bronchogenic carcinoma (Willclnson and Zeromski, 1965) .
Myasthenic Syndromes
The role of the thymus and thymoma in myasthcnia gravis continues to be enigmatic. The affinity of myasthenic serum for the A-band of striated muscle seems irrelevant to a synaptic disease although Van de Velde and Friedman (1966) confirmed by electron-microscopy the old observation of "Myoidzellcn" in the thymus. Recently we learn that myasthenie serum contains antibodies with affinity for neurons and even spermatogonia (Kornguth et al., 1970) .
Rarely myasthenia patients manifest reflex loss and muscle wasting, i.e. myopathy, in addition to the fatigability. Such patients usually have a poor response to anticholinesterase medications but are very sensitive to muscle relaxant drugs used as adjuncts to anesthesia. Some of the first cases came to attention when they failed to regain adequate spontaneous respiration after such an anesthesia. The great majority of these cases have had lung cancer, most frequently an oat-cell bronchogenie carcinoma.
This myasthenic myopathy (or Lambert-Eaton syndrome) is notable for the frequent occurrence of the neurologic disorder before the neoplasm. Further study of this myopathy has confirmed the presence of a defect in mobilization or release of transmitter quanta from the terminal axon in response to nerve impulses (Hofmann et al., 1967) . The defect is improved by guanidine (Elmqvist and Lamber~, 1968) , which remains the treatment of choice. A recent case is notable for the concurrence of inappropriate ADIt secretion, presumably also caused by the lung lesion (Kennedy and Jimenez-Pabon, 1968) . The detection of "curare-like substance" in extracts of the bronchogenic tumors in two cases (Kennedy et al., 1969) must be viewed with caution in the absence of essential details such as the potassium ion concentrations of the extracts, although it seems reasonable to anticipate discovery of a botulinum-like substance in tumor extracts.
M y o p a t h i e s : N e u r o m u s c u l a r Disorders
As noted at the outset, two or more of the neurologic syndromes may occur in one patient, a problem which is encountered most often in combinations of neuropathy, myasthenia and myopathy. The pioneer English investigators found the term carcinomatous neuromyopathy or neuromuscular disorder useful for practical clinical purposes.
A further problem is the differentiation of myopathy (without significant inflammation) from polymyositis. Both patients may present an identical clinical problem in subacute or chronic, proximal, bilateral, muscle weakness. There may be little muscle wasting although in both conditions the muscle stretch reflexes are usually depressed or absent. The muscle biopsy can prove confusing; probably owing to the sampling error inherent in any biopsy, the histology may reveal little or no inflammatory change even when severe muscle pain and benefit from corticosteroid medication convince the clinican that the diagnosis is polymyositis. Conversely, there may be inflammation in the biopsy of a degenerative myopathy such as childhood muscular dystrophy.]
The association of polymyositis with dermatitis (dermatomyositis), and positive tests for collagen-vascular disease, raise the possibility of an auto-immune mechanism. Goldstein (1968) reported that injections of thymie extract in guinea-pigs produce a myasthenic myositis which, if confirmed, may be relevant to this problem. The latest development in myositis, however, is the finding of virus-like particles in the electron microscope (Chou, 1968; Norris el al., 1969; Chou and Gutmann, 1970) , though none have been found as yet in muscle from cancer patients. Further studies are obviously needed.
Discussion
Hildebrand and CSers (1967) detected more subclinical abnormalities in emaciated cancer patients, which led them to suggest that malnutrition accounts for some neuromuscular findings. Wi]ner and Brody (1968) conclude, from study of a group of veterans hospitalized because of chronic lung disease, that many instances of these neuromuscular effects of cancer may be nonspecific manifestations of any chronic debilitating disease. This could be true in some cases, such as the type A neuropathy (see above) of Croft et al. (1967) , but does not diminish our responsibility to identify the cases and seek the mechanism and treatment. Shy and Sflverstein (1965) believed that the occurrence of major malignancies in 9 of their 186 patients with an amyotrophie neurologic picture merely indicated the coincidence of common diseases. Major neoplasms are actually not very prevalent although they are an important cause of death; most of these neurologic syndromes are also uncommon except in neurologic clinics. The risk of two potentially lethal but unrelated diseases in one individual, at the same time in life, should be less than the risk of just one of these diseases.
There is, however, general agreement on the significance of such very rare and close associations as multifoeal leukoencephalopathy with lymphoma or leukemia and the Lambert-Eaton myasthenic myopathy with oat-cell carcinoma.
The relatively pure or specific neurologic syndromes occupy the lion's share of attention in this review, but most remote effects of cancer are mixed in type : many patients have manifestations of two or more of the neurologie syndromes, and now endocrine disorders are also being detected in increasing numbers of cases. Further studies are needed, particularly in search for antigenic and viral agents. There is also need to search for a botulinum-like agent in oat-cell carcinoma and for an EAE-inducing agent in neuroblastoma.
Another area for fruitful study is the metabolism and immune mechanism of the cancer patient. For example, the notorious association between lymphoma and herpes zoster may be based on inadequate interferon production in the cutaneous vesicles (Armstrong et al., 1970) .
Certainly m u c h remains to be said a b o u t all the remote effects, and final opinions m u s t await further research a n d still greater clinical experience. E v e n the well-known cachexia of cancer patients seems poorly understood (De Wys, 1970) .
Note Added in Proo[: An apparently different papovavirus seems to have been isolated in two recent cases of PML (Weiner et al., 1972) .
